EGF and neoplasm: ECM1 is known to interact with the EGF domain on other proteins, such as perlecan [25], and perlecan may induce heparin-binding growth factor responses, including the fibroblast growth factor 2 (FGF2) response, and thereby promote tumor growth [34].